DrugCite
Search

FORLAX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Forlax Adverse Events Reported to the FDA Over Time

How are Forlax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Forlax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Forlax is flagged as the suspect drug causing the adverse event.

Most Common Forlax Adverse Events Reported to the FDA

What are the most common Forlax adverse events reported to the FDA?

Pruritus
22 (2.57%)
Renal Failure Acute
21 (2.45%)
Eczema
20 (2.34%)
Hyponatraemia
18 (2.1%)
Prurigo
17 (1.99%)
Fall
14 (1.64%)
Eosinophilia
13 (1.52%)
Hypotension
12 (1.4%)
Death
11 (1.29%)
Dyspnoea
11 (1.29%)
Hypokalaemia
11 (1.29%)
Show More Show More
International Normalised Ratio Incr...
11 (1.29%)
Pyrexia
11 (1.29%)
Anaemia
10 (1.17%)
Bradycardia
9 (1.05%)
Chest Pain
9 (1.05%)
Diarrhoea
9 (1.05%)
Gastrointestinal Haemorrhage
9 (1.05%)
Neutropenia
9 (1.05%)
Pancreatitis Acute
9 (1.05%)
Pruritus Generalised
9 (1.05%)
Vomiting
9 (1.05%)
Acute Respiratory Distress Syndrome
8 (.93%)
Confusional State
8 (.93%)
Interstitial Lung Disease
8 (.93%)
Leukopenia
8 (.93%)
Lung Disorder
8 (.93%)
Metabolic Acidosis
8 (.93%)
Overdose
8 (.93%)
Pelvic Pain
8 (.93%)
Rash Maculo-papular
8 (.93%)
Atrioventricular Block Complete
7 (.82%)
C-reactive Protein Increased
7 (.82%)
Cerebellar Syndrome
7 (.82%)
Condition Aggravated
7 (.82%)
Cyanosis
7 (.82%)
Dehydration
7 (.82%)
Epilepsy
7 (.82%)
Gait Disturbance
7 (.82%)
Rectal Haemorrhage
7 (.82%)
Subdural Haematoma
7 (.82%)
Cardio-respiratory Arrest
6 (.7%)
Cerebral Haemorrhage
6 (.7%)
Coma
6 (.7%)
Convulsion
6 (.7%)
Disorientation
6 (.7%)
Encephalopathy
6 (.7%)
Faecal Vomiting
6 (.7%)
Haematoma
6 (.7%)
Hyperkalaemia
6 (.7%)
Hyperlactacidaemia
6 (.7%)
Muscle Haemorrhage
6 (.7%)
Night Sweats
6 (.7%)
Oedema Peripheral
6 (.7%)
Stevens-johnson Syndrome
6 (.7%)
Thrombocytopenia
6 (.7%)
Bilirubin Conjugated Increased
5 (.58%)
Blood Alkaline Phosphatase Increase...
5 (.58%)
Blood Creatinine Increased
5 (.58%)
Cytolytic Hepatitis
5 (.58%)
Haemorrhoids
5 (.58%)
Hypovolaemia
5 (.58%)
Inflammation
5 (.58%)
Loss Of Consciousness
5 (.58%)
Malaise
5 (.58%)
Respiratory Disorder
5 (.58%)
Subcutaneous Haematoma
5 (.58%)
Eye Rolling
4 (.47%)
Gamma-glutamyltransferase Increased
4 (.47%)
Hyperhidrosis
4 (.47%)
Renal Failure
4 (.47%)
Somnolence
4 (.47%)
Toxic Skin Eruption
4 (.47%)
Urinary Incontinence
4 (.47%)
Atrial Fibrillation
3 (.35%)
Cardiac Failure
3 (.35%)
Cholestasis
3 (.35%)
Cough
3 (.35%)
Dermatitis Exfoliative
3 (.35%)
Drug Eruption
3 (.35%)
Drug Exposure During Pregnancy
3 (.35%)
Drug Interaction
3 (.35%)
Electrocardiogram Qt Prolonged
3 (.35%)
Eosinophil Count Increased
3 (.35%)
General Physical Health Deteriorati...
3 (.35%)
Haemoglobin Decreased
3 (.35%)
Haemothorax
3 (.35%)
Hepatitis
3 (.35%)
Humerus Fracture
3 (.35%)
Intestinal Ischaemia
3 (.35%)
Myocardial Ischaemia
3 (.35%)
Myoclonus
3 (.35%)
Nausea
3 (.35%)
Pregnancy With Contraceptive Device
3 (.35%)
Pulmonary Embolism
3 (.35%)
Pulmonary Fibrosis
3 (.35%)
Rash Generalised
3 (.35%)
Tonic Clonic Movements
3 (.35%)
Acute Generalised Exanthematous Pus...
2 (.23%)
Aggression
2 (.23%)
Agitation
2 (.23%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Forlax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Forlax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Forlax

What are the most common Forlax adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Forlax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Forlax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Forlax According to Those Reporting Adverse Events

Why are people taking Forlax, according to those reporting adverse events to the FDA?

Constipation
233
Drug Use For Unknown Indication
223
Product Used For Unknown Indication
60
Constipation Prophylaxis
15
Unevaluable Event
5
General Symptom
4
Show More Show More
Dyspepsia
4
Cholecystectomy
4
Gastrointestinal Disorder
3
Ill-defined Disorder
3
Laxative Supportive Care
3
Diverticulum Intestinal
1
Gastric Disorder
1
Colonoscopy
1
Sinusitis
1
Irritable Bowel Syndrome
1
Dyslipidaemia
1

Forlax Case Reports

What Forlax safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Forlax. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Forlax.